Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gammaplex vs Vigam Liquid PK Study
NCT02246855Phase 1Completed
- Sponsor
- Bio Products Laboratory
- Start
- Aug 2004
- Primary completion
- Dec 2004
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of polyvalent human immunoglobulin in primary immunodeficiency (PI) (3 arms), sponsored by Bio Products Laboratory. Primary endpoint: Pharmacokinetic parameters for serum immunoglobulin G (IgG) at Day 85. Started Aug 2004; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT02246855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246855.